Dendritic Cells and T Cells in the Regulation of Cutaneous Immunity

Advances in Dermatology

Volumn 23, Issue , 2007, Pages 307-333

  Loser, Karin ^a   Beissert, Stefan ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; LEUKOCYTE ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR;

ANIMAL; DENDRITIC CELL; HUMAN; IMMUNOLOGY; LANGERHANS CELL; METABOLISM; PHYSIOLOGY; REGULATORY T LYMPHOCYTE; REVIEW; SKIN; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIGENS, CD; CYTOKINES; DENDRITIC CELLS; HUMANS; LANGERHANS CELLS; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; SKIN; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY;

EID: 36048942044     PISSN: 08820880     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.yadr.2007.07.014     Document Type: Review

References (153)

1. Valladeau J., Duvert-Frances V., Pin J.J., et al. The monoclonal antibody DCGM4 recognizes Langerin, a protein specific of Langerhans cells, and is rapidly internalized from the cell surface. Eur J Immunol 29 (1999) 2695-2704
2. Valladeau J., Ravel O., Dezutter-Dambuyant C., et al. Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity 12 (2000) 71-81
3. Valladeau J., Clair-Moninot V., Dezutter-Dambuyant C., et al. Identification of mouse langerin/CD207 in Langerhans cells and some dendritic cells of lymphoid tissues. J Immunol 168 (2002) 782-792
4. Romani N., Holzmann S., Tripp C.H., et al. Langerhans cells-dendritic cells of the epidermis. APMIS 111 (2003) 725-740
5. Valladeau J., and Saeland S. Cutaneous dendritic cells. Semin Immunol 17 (2005) 273-283
6. Bogunovic M., Ginhoux F., Wagers A., et al. Identification of a radio-resistant and cycling dermal dendritic cell population in mice and man. J Exp Med 203 (2006) 2627-2638
7. Rowden G., Lewis M.G., and Sullivan A.K. Ia antigen expression on human epidermal Langerhans cells. Nature 268 (1977) 247-248
8. Klareskog L., Malmnas-Tjernlund U., Forsum U., et al. Epidermal Langerhans cells express Ia antigens. Nature 268 (1977) 248-250
9. Stingl G., Wolff-Schreiner E.C., Pichler W.J., et al. Epidermal Langerhans cells bear Fc and C3 receptors. Nature 268 (1977) 245-246
10. Langerhans P. [About the nerves in human skin.]. Virchows Archir [A] 44 (1868) 325-337 [in German]
11. Birbeck M.S., Breathnach A.S., and Everall J.D. An electron microscope study of basal melanocytes and high-level clear cells (Langerhans cells) in vitiligo. J Invest Dermatol 37 (1961) 51
12. Wolff K. The fine structure of the Langerhans cell granule. J Cell Biol 35 (1967) 468-473
13. Takahara K., Omatsu Y., Yashima Y., et al. Identification and expression of mouse Langerin (CD207) in dendritic cells. Int Immunol 14 (2002) 433-444
14. Valladeau J., Dezutter-Dambuyant C., and Saeland S. Langerin/CD207 sheds light on formation of birbeck granules and their possible function in Langerhans cells. Immunol Res 28 (2003) 93-107
15. Tang A., Amagai M., Granger L.G., et al. Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin. Nature 361 (1993) 82-85
16. Kissenpfennig A., Ait-Yahia S., Clair-Moninot V., et al. Disruption of the langerin/CD207 gene abolishes Birbeck granules without a marked loss of Langerhans cell function. Mol Cell Biol 25 (2005) 88-99
17. De Witte L., Nabatov A., Pion M., et al. Langerin is a natural barrier to HIV-1 transmission by Langerhans cells. Nat Med 13 (2007) 367-371
18. Green E.A., Choi Y., and Flavell R.A. Pancreatic lymph node derived CD4+CD25+ Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals. Immunity 16 (2002) 183-191
19. Schuler G., and Steinman R.M. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J Exp Med 161 (1985) 526-546
20. Romani N., Koide S., Crowley M., et al. Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells. J Exp Med 169 (1989) 1169-1178
21. Macatonia S.E., Knight S.C., Edwards A.J., et al. Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. Functional and morphological studies. J Exp Med 166 (1987) 1654-1667
22. Borkowski T.A., van Dyke B.J., Schwarzenberger K., et al. Expression of E-cadherin by murine dendritic cells. E-cadherin as a dendritic cell differentiation antigen characteristic of epidermal Langerhans cells and related cells. Eur J Immunol 158 (1994) 4543-4547
23. Cumberbatch M., Dearman R.J., and Kimber I. Adhesion molecule expression by epidermal Langerhans cells and lymph node dendritic cells: a comparison. Arch Dermatol Res 288 (1996) 739-744
24. Jakob T., and Udey M.C. Regulation of E-cadherin-mediated adhesion in Langerhans cell-like dendritic cells by inflammatory mediators that mobilize Langerhans cells in vivo. J Immunol 169 (1998) 4067-4073
25. Cumberbatch M., Fielding I., and Kimber I. Modulation of epidermal Langerhans cell frequency by tumor necrosis factor-a. Immunology 81 (1994) 395-401
26. Cumberbatch M., Dearman R.J., and Kimber I. Interleukin 1β and the stimulation of Langerhans cell migration: comparisons with tumor necosis factor-α. Arch Dermatol Res 289 (1997) 277-284
27. Cumberbatch M., Dearman R.J., and Kimber I. Langerhans cells require signals from both tumor necrosis factor-α and interleukin-1β for migration. Immunology 92 (1997) 388-395
28. Cumberbatch M., Dearman R.J., and Kimber I. Langerhans cell migration in mice requires intact type I interleukin 1 receptor (IL-1RI) function. Arch Dermatol Res 291 (1999) 357-361
29. Wang B., Kondo S., Shivji G.M., et al. Tumor necrosis factor receptor II (p75) signalling is required for the migration of Langerhans cells. Immunology 88 (1996) 284-288
30. Cumberbatch M., Griffiths C.E.M., Tucker S.C., et al. Tumor necrosis factor-α induces Langerhans cell migration in humans. Br J Dermatol 141 (1999) 192-200
31. Cumberbatch M., Bhushan M., Dearman R.J., et al. IL-1beta-induced Langerhans cell migration and TNF-alpha production in human skin: regulation by lactoferrin. Clin Exp Immunol 132 (2003) 352-359
32. Ohl L., Mohaupt M., Czeloth N., et al. CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity 21 (2004) 279-288
33. Katz S.I., Tamaki K., and Sachs D.H. Langerhans cells are derived from cells originating in bone marrow. Nature 282 (1979) 324-326
34. Krueger G.G., Daynes R.A., and Emam M. Biology of Langerhans cells: selective migration of Langerhans cells into allogeneic and xenogeneic grafts on nude mice. Proc Natl Acad Sci USA 80 (1983) 1650-1654
35. Merad M., Manz M.G., Karsunky H., et al. Langerhans cells renew in the skin throughout life under steady-state conditions. Nat Immunol 3 (2002) 1135-1141
36. Ginhoux F., Tacke F., Angeli V., et al. Langerhans cells arise from monocytes in vivo. Nat Immunol 7 (2006) 265-273
37. Larregina A.T., Morelli A.E., Spencer L.A., et al. Dermal-resident CD14+ cells differentiate into Langerhans cells. Nat Immunol 2 (2001) 1151-1158
38. Schaerli P., Willimann K., Ebert L.M., et al. Cutaneous CXCL14 targets blood precursors to epidermal niches for Langerhans cell differentiation. Immunity 23 (2005) 331-342
39. Kanitakis J., Petruzzo P., and Dubernard J.M. Turnover of epidermal Langerhans cells. N Engl J Med 351 (2004) 2661-2662
40. Toews G.B., Bergstresser P.R., and Streilein J.W. Epidermal Langerhans cell density determines whether contact hypersensitivity or unresponsiveness follows skin painting with DNFB. J Immunol 124 (1980) 445-453
41. Streilein J.W., and Bergstresser P.R. Langerhans cell function dictates induction of contact hypersensitivity or unresponsiveness to DNFB in Syrian hamsters. J Invest Dermatol 77 (1981) 272-277
42. Streilein J.W., Lonsberry L.W., and Bergstresser P.R. Depletion of epidermal Langerhans cells and Ia immunogenicity from tape-stripped mouse skin. J Exp Med 155 (1982) 863-871
43. Riemann H., Loser K., Beissert S., et al. IL-12 breaks dinitrothiocyanobenzene (DNTB)-mediated tolerance and converts the tolerogen DNTB into an immunogen. J Immunol 175 (2005) 5866-5874
44. Grabbe S., Steinbrink K., Steinert M., et al. Removal of the majority of epidermal Langerhans cells by topical or systemic steroid application enhances the effector phase of murine contact hypersensitivity. J Immunol 155 (1995) 4207-4217
45. Zhao X.Y., Deak E., Soderberg K., et al. Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2. J Exp Med 197 (2003) 153-162
46. Ritter U., Meissner A., Scheidig C., et al. CD8α- and Langerin-negative dendritic cells, but not Langerhans cells, act as principal antigen-presenting cells in Leishmaniasis. Eur J Immunol 34 (2004) 1542-1550
47. Kissenpfennig A., Henri S., Dubois B., et al. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 22 (2005) 643-654
48. Bennett C.L., van Rijn E., Jung S., et al. Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J Cell Biol 169 (2005) 569-576
49. Kaplan D.H., Jenison M.C., Saeland S., et al. Epidermal Langerhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity 23 (2005) 611-620
50. Mayerova D., Parke E.A., Bursch L.S., et al. Langerhans cells activate naive self-antigen specific CD8 T cells in the steady state. Immunity 21 (2004) 391-400
51. Shibaki A., Sato A., Vogel J.C., et al. Induction of GVHD-like skin disease by passively transferred T cell receptor transgenic CD8+ T cells into keratin-14-ovalbumin transgenic mice. J Invest Dermatol 123 (2004) 109-115
52. Azukizawa H., Kosaka H., Sano S., et al. Induction of T-cell-mediated skin disease specific for antigen transgenically expressed in keratinocytes. Eur J Immunol 33 (2003) 1879-1888
53. Stoitzner P., Holzmann S., McLellan A., et al. Visualization and characterization of migratory Langerhans cells in murine skin and lymph nodes by antibodies against langerin/CD207. J Invest Dermatol 120 (2003) 266-274
54. Brenner B., Koppenhoefer U., Grassme H., et al. Evidence for a novel function of the CD40 ligand as a signalling moleule in T-lymphocytes. FEBS Lett 417 (1997) 301-306
55. Cella M., Scheidegger D., Palmer-Lehmann K., et al. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 184 (1996) 747-752
56. Mehling A., Loser K., Varga G., et al. Overexpression of CD40 ligand in murine epidermis results in chronic skin inflammation and systemic autoimmunity. J Exp Med 194 (2001) 615-628
57. Loser K., Balkow S., Higuchi T., et al. FK506 controls CD40L-induced systemic autoimmunity in mice. J Invest Dermatol 126 (2006) 1307-1315
58. Dubois S.P., Waldmann T.A., and Müller J. Survival adjustment of mature dendritic cells by IL-15. Proc Natl Acad Sci USA 102 (2005) 8662-8667
59. Jinushi M., Takehara T., Tatsumi T., et al. Autocrine/paracrine IL-15 that is required for type I IFN-mediated dendritic cell expression of MHC class I-related chain A and B is impaired in hepatitis C virus infection. J Immunol 171 (2003) 5423-5429
60. Mattei F., Schiavoni G., Belardelli F., et al. IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation. J Immunol 167 (2001) 1179-1187
61. Loser K., Mehling A., Apelt J., et al. Enhanced contact hypersensitivity and antiviral immune responses in vivo by keratinocyte-targeted overexpression of IL-15. Eur J Immunol 34 (2004) 2022-2031
62. Loser K., Mehling A., Loeser S., et al. Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells. Nat Med 12 (2006) 1372-1379
63. Mahnke K., Quian Y., Knop J., et al. Induction of CD4+CD25+ regulatory T cells by targeting of antigens to immature dendritic cells. Blood 101 (2003) 4862-4869
64. Streilein J.W. Antigen-presenting cells in the induction of contact hypersensitivity in mice: evidence that Langerhans cells are sufficient but not required. J Invest Dermatol 93 (1989) 443-448
65. Geijtenbeek T.B., Torensma R., van Vliet S.J., et al. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 100 (2000) 575-585
66. Figdor C.G., van Kooyk Y., and Adema G.J. C-type lectin receptors on dendritic cells and Langerhans cells. Nat Rev Immunol 2 (2002) 77-84
67. Valladeau J., Duvert-Frances V., Pin J.J., et al. Immatue human dendritic cells express asialoglycoprotein receptor isoforms for efficient receptor-mediated endocytosis. J Immunol 167 (2001) 5767-5774
68. Van Kooyk Y., and Geijtenbeek T.B. DC-SIGN: escape mechanism for pathogens. Nat Rev Immunol 3 (2003) 697-709
69. Caux C., Massacrier C., Vanbervliet B., et al. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor α2. Functional analysis. Blood 90 (1997) 1458-1470
70. Girardi M. Immunosurveillance and immunoregulation by γδ T cells. J Invest Dermatol 126 (2006) 25-31
71. Bergstresser P.R., Sullivan S., Streilein J.W., et al. Origin and function of Thy-1+ dendritic epidermal cells in mice. J Invest Dermatol 85 Suppl 1 (1985) 85S-90S
72. Elloso M.M., Wallace M., Manning D.D., et al. The effects of interleukin-15 on human gammadelta T cell responses to Plasmodium falciparum in vitro. Immunol Lett 64 (1998) 125-132
73. French J.D., Roark C.L., Born W.K., et al. Gammadelta T cell homeostasis is established in competition with alphabeta T cells and NK cells. Proc Natl Acad Sci USA 102 (2005) 14741-14746
74. Girardi M., Oppenheim D.E., Steele C.R., et al. Regulation of cutaneous malignancy by γδ T cells. Science 294 (2001) 605-609
75. Girardi M., Glusac E., Filler R.B., et al. The distinct contributions of murine T cell receptor (TCR)γδ+ and TCRαβ+ T cells to different stages of chemically induced skin cancer. J Exp Med 198 (2003) 747-755
76. Gao Y., Yang W., Pan M., et al. γδT cells provide an early source of interferon γ in tumor immunity. J Exp Med 198 (2003) 433-442
77. Holtmeier W., Pfander M., Hennemann A., et al. The TCR-d repertoire in normal human skin is restricted and distinct from the TCR-δ repertoire in peripheral blood. J Invest Dermatol 116 (2001) 275-280
78. Ebert L.M., Meuter S., and Moser B. Homing of human skin γδ T cells and NK cells: relevance for tumor surveillance. J Immunol 176 (2006) 4331-4336
79. Girardi M., Lewis J., Glusac E., et al. Resident skin-specific γδ T cells provide local, nonredundant regulation of cutaneous inflammation. J Exp Med 195 (2002) 855-867
80. Pennington D.J., Vermijlen D., Wise E.L., et al. The integration of conventional and unconventional T cells that characterizes cell-mediated responses. Adv Immunol 87 (2005) 27-59
81. Gershon R.K., and Kondo K. Cell interactions in the induction of tolerance: the role of thymic lymphocytes. Immunology 18 (1970) 723-737
82. Kojima A., Taguchi O., and Nishizuka Y. Experimental production of possible autoimmune castritis followed by macrocytic anemia in athymic nude mice. Lab Invest 42 (1980) 387-395
83. Taguchi O., Kojima A., and Nishizuka Y. Experimental autoimmune prostatitis after neonatal thymectomy in the mouse. Clin Exp Immunol 60 (1985) 123-129
84. Taguchi O., and Nishizuka Y. Experimental autoimmune orchitis after neonatal thymectomy in the mouse. Clin Exp Immunol 46 (1981) 425-434
85. Taguchi O., and Nishizuka Y. Autoimmune oophoritis in thymectomized mice: T cell requirement in adoptive cell transfer. Clin Exp Immunol 42 (1980) 324-331
86. Sakaguchi S., Sakaguchi N., Asano M., et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155 (1995) 1151-1164
87. Russell W.L., Russell L.B., and Gower J.S. Exceptional inheritance of a sex-linked gene in the mouse explained on the basis that the X/O sex-chromosome constitution is female. Proc Natl Acad Sci USA 45 (1959) 554-560
88. Godfrey V., Rouse B.T., and Wilkinson J.E. Transplantation of T cell-mediated lymphoreticular disease from the scurfy (sf) mouse. Am J Pathol 145 (1994) 281-286
89. Brunkow M.E., Jeffery E.W., Hjerrild K.A., et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 27 (2001) 68-73
90. Khattri R., Kasprowicz D.J., Cox T., et al. The amount of scurfin protein determines peripheral T cell number and responsiveness. J Immunol 167 (2001) 6312-6370
91. Fontenot J.D., Gavin M.A., and Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4 (2003) 330-336
92. Hori S., Nomura T., and Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299 (2003) 1057-1061
93. Khattri R., Cox T., Yasayko S.-A., et al. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 4 (2003) 337-342
94. Fontenot J.D., Rasmussen J.P., Williams L.M., et al. Regulatory T cell lineage specification by the forkhead transcription factor Foxp3. Immunity 22 (2005) 329-341
95. Loser K., Apelt J., and Beissert S. T cells and dendritic cells in immuno-mediated skin pathology. In: Sarzi-Puttini P., Doria A., Girolomoni G., and Kuhn A. (Eds). The skin in systemic autoimmune disease. Handbook of systemic autoimmune diseases. vol. 5 (2006), Amsterdam: Elsevier 11-21
96. Loser K., and Beissert S. Therapeutic modulation of cutaneous autoimmunity by regulatory T cells. Rheumatology 45 Suppl 3 (2006) iii20-iii22
97. Roncador G., Brown P.J., Maestre L., et al. Analysis of Foxp3 protein expression in human CD4+CD25+ regulatory T-cells at the single-cell level. Eur J Immunol 35 (2005) 1681-1691
98. Loser K., Scherer A., Krummen M.B.W., et al. An important role of CD80/CD86-CTLA-4 signaling during photocarcinogenesis in mice. J Immunol 174 (2005) 5298-5305
99. Takahashi T., Tagami T., Yamazaki S., et al. Immunologic self tolerance maintained by CD25+CD4+ regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 192 (2000) 303-310
100. Read S., Malmstrom V., and Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25+CD4+ regulatory cells that control intestinal inflammation. J Exp Med 192 (2000) 295-302
101. Tang Q., Boden E.K., Henriksen K.J., et al. Distinct roles of CTLA-4 and TGF-beta in CD4+CD25+ regulatory T cell function. Eur J Immunol 34 (2004) 2996-3005
102. Shimizu J., Yamazaki S., Takahashi T., et al. Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 3 (2002) 135-142
103. high, Foxp3-expressing CD25+ and CD25- regulatory T cells. J Immunol 176 (2006) 4748-4756
104. McHugh R.S., Whitters M.J., Piccirillo C.A., et al. CD4+CD25+ immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16 (2002) 311-323
105. Vijayakrishnan L., Slavik J.M., Illes Z., et al. An autoimmune disease-associated CTLA-4 splice variant lacking the B7 binding domain signals negatively in T cells. Immunity 20 (2004) 563-575
106. Nocentini G., and Riccardi C. GITR: a multi-faceted regulator of immunity belonging to the tumor necrosis factor receptor superfamily. Eur J Immunol 35 (2005) 1016-1022
107. Bruder D., Probst-Kepper M., Westendorf A.M., et al. Neuropilin-1: a surface marker of regulatory T cells. Eur J Immunol 34 (2004) 623-630
108. Loser K., Hansen W., Apelt J., et al. In vitro-generated regulatory T cells induced by Foxp3-retrovirus infection control murine contact allergy and systemic autoimmunity. Gene Ther 12 (2005) 1294-1304
109. Hansen W., Loser K., Westendorf A.M., et al. G protein coupled receptor 83 overexpression in naive CD4+CD25- T cells leads to the induction of Foxp3 regulatory T cells in vivo. J Immunol 177 (2006) 209-215
110. Schorle H., Holtschke T., Hunig T., et al. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 352 (1991) 621-624
111. Sadlack B., Merz H., Schorle H., et al. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75 (1993) 253-261
112. Suzuki H., Kundig T.M., Furlonger G., et al. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science 268 (1995) 1472-1476
113. Almeida A.R., Legrand N., Papiernik M., et al. Homeostasis of peripheral CD4+ T cells: IL-2R alpha and IL-2 shape a population of regulatory cells that controls CD4+ T cell numbers. J Immunol 169 (2002) 4850-4860
114. Furtado G.C., Curotto de Lafaille M.A., Kutchukhidze N., et al. Interleukin-2 signaling is required for CD4+ regulatory T cell function. J Exp Med 196 (2002) 851-857
115. Fontenot J.D., Rasmussen J.P., Gavin M.A., et al. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 6 (2005) 1142-1151
116. Thornton A.M., Piccirillo C.A., and Shevach E.M. Activation requirements for the induction of CD4+CD25+ T cell suppressor function. Eur J Immunol 34 (2004) 366-376
117. Zheng S.G., Gray J.D., Ohtsuka K., et al. Generation ex vivo of TGF-beta-producing regulatory T cells from CD4+CD25- precursors. J Immunol 169 (2002) 4183-4189
118. Chen W., Jin W., Hardegen N., et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198 (2003) 1875-1886
119. Horwitz D.A., Zheng S.G., and Gray J.D. The role of the combination of IL-2 and TGF-beta or IL-10 in the generation and function of CD4+CD25+ and CD8+ regulatory T cell subsets. J Leukoc Biol 74 (2003) 471-478
120. Marie J.C., Letterio J.J., Gavin M., et al. TGF-beta 1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells. J Exp Med 201 (2005) 1061-1067
121. Huber S., Schramm C., Lehr H.A., et al. Cutting edge: TGF-beta signaling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4+CD25+ T cells. J Immunol 173 (2004) 6526-6531
122. Groux H., O'Garra A., Bigler M., et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389 (1997) 737-742
123. Bacchetta R., Sartirana C., Levings M.K., et al. Growth and expansion of human T regulatory type I cells are independent from TCR activation but require exogenous cytokines. Eur J Immunol 32 (2002) 2237-2245
124. Asseman C., Mauze S., Leach M.W., et al. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 190 (1999) 995-1004
125. Von Boehmer H. Mechanisms of suppression by suppressor T cells. Nat Immunol 6 (2005) 338-344
126. Gondek D.C., Lu L.F., Quezada S.A., et al. Cutting edge: contact mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent perforin-independent mechanism. J Immunol 174 (2005) 1783-1786
127. Tang Q., Adams J.Y., Tooley A.J., et al. Visualizing regulatory T cell control of autoimmune responses in non-obese diabetic mice. Nat Immunol 7 (2006) 83-92
128. Graca L., Cobbold S.P., and Waldmann H. Identification of regulatory T cells in tolerated allografts. J Exp Med 195 (2002) 1641-1646
129. Yu P., Lee Y., Liu W., et al. Intratumor depletion of CD4+ T cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors. J Exp Med 201 (2005) 779-791
130. Zhao D.M., Thornton A.M., DiPaolo R.J., et al. Activated CD4+CD25+ T cells selectively kill B lymphocytes. Blood 107 (2006) 3925-3932
131. Shevach E.M., DiPaolo R.A., Andersson J., et al. The lifestyle of naturally occurring CD4+CD25+Foxp3+ regulatory T cells. Immunol Rev 212 (2006) 60-73
132. Viglietta V., Baecher-Allan C., Weiner H.L., et al. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 199 (2004) 971-979
133. Liu M.F., Wang C.R., Fung L.L., et al. Decreased CD4+CD25+ T cells in peripheral blood of patients with systemic lupus erythematosus. Scand J Immunol 59 (2004) 198-202
134. bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J Immunol 172 (2004) 6435-6443
135. Bovenschen H.J., van Vlijmen-Willems I.M.J.J., van de Kerkof P.C.M., et al. Identification of lesional CD4+CD25+Foxp3+ regulatory T cells in psoriasis. Dermatology 213 (2006) 111-117
136. high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation. J Immunol 174 (2005) 164-173
137. Ling E.M., Smith T., Nguyen X.D., et al. Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 363 (2004) 608-615
138. Grindebacke H., Wing K., Andersson A.C., et al. Defective suppression of Th2 cytokines by CD4CD25 regulatory T cells in birch allergics during birch pollen season. Clin Exp Allergy 34 (2004) 1364-1372
139. Shimizu J., Yamazaki S., and Sakaguchi S. Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity. J Immunol 163 (1999) 5211-5218
140. Gray C.P., Arosio P., and Hersey P. Heavy chain ferritin activates regulatory T cells by induction of changes in dendritic cells. Blood 99 (2002) 3326-3334
141. Gray C.P., Arosio P., and Hersey P. Association of increased levels of heavy-chain ferritin with increased CD4+CD25+ regulatory T cell levels in patients with melanoma. Clin Cancer Res 9 (2003) 2551-2559
142. high regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells. J Immunol 173 (2004) 1444-1453
143. Schaefer C., Kim G.G., Albers A., et al. Characteristics of CD4+CD25+ regulatory T cells in the peripheral circulation of patients with head and neck cancer. Br J Cancer 92 (2005) 913-920
144. Wolf D., Rumpold H., Koppelstatter C., et al. Telomere length of in vivo expanded CD4+CD25+ regulatory T cells is preserved in cancer patients. Cancer Immunol Immunother 55 (2006) 1198-1208
145. Yamazaki S., Iyoda T., Tarbell K., et al. Direct expansion of functional CD25+CD4+ regulatory T cells by antigen processing dendritic cells. J Exp Med 198 (2003) 235-247
146. Takahashi T., Kuniyasu Y., Toda M., et al. Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 10 (1998) 1969-1980
147. Tang Q., Henriksen K.J., Boden E.K., et al. Cutting edge: CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T cells. J Immunol 171 (2003) 3348-3352
148. Kumanogoh A., Wang X., Lee I., et al. Increased T cell autoreactivity in the absence of CD40-CD40 ligand interactions: a role of CD40 in regulatory T cell development. J Immunol 166 (2001) 353-360
149. Jonuleit H., Schmitt E., Schuler G., et al. Induction of interleukin 10-producing nonproliferating CD4+ T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 192 (2000) 1213-1222
150. Tang Q., Henriksen K.J., Bi M., et al. In vitro expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med 199 (2004) 1455-1465
151. Tarbell K.V., Yamazaki S., Olson K., et al. CD25+CD4+ T cells, expanded with dendritic cells presenting a single auto-antigenic peptide suppress autoimmune diabetes. J Exp Med 199 (2004) 1467-1477
152. Veldman C., Hohne A., Dieckmann D., et al. Type I regulatory T cells specific for desmoglein-3 are more frequently detected in healthy individuals than in patients with pemphigus vulgaris. J Immunol 172 (2004) 6468-6475
153. Allan R.S., Smith C.M., Belz G.T., et al. Epidermal viral immunity induced by CD8alpha+ dendritic cells but not by Langerhans cells. Science 301 (2003) 1925-1928